Today, we’re launching Mendra, a rare disease therapeutics company enabled by AI.
We’re announcing an oversubscribed $82M Series A co-led by @OrbiMed, @8vc, and @5amVentures with participation from @Lux_Capital and @Wing_VC.
Full announcement 👇
https://t.co/rjxxWMa3Nu
Ten years ago, I joined @PalantirTech because the problems felt impossible to ignore. Deploying software for mission-critical systems in life sciences and aerospace where failure wasn’t abstract. That weight shaped how I think about work.
I’m bringing that same weight to something new.
Today, we’re announcing @MendraInc with $82 million to acquire, develop, and commercialize therapies for rare diseases. These conditions affect millions of people, yet most still have no approved treatment and are often undiagnosed or misdiagnosed. Many of these conditions present in childhood.
Becoming a parent made this personal. It sharpened the stakes. Rare disease development and commercialization is a systems problem. Advances in data orchestration and AI now make it possible to identify patients and accelerate delivery of therapeutics in ways that simply weren’t feasible years ago.
Immensely grateful to my Palantir family for the last decade, and to the team I’m building with at @MendraInc. Let’s go!
Thanks again to @NASAGeneLab and all the co-authors for all their incredible work. It was a pleasure to be involved with the work, major props the joint first authors, Rebecca Finch and Geraldine Vitry, and of course the Senior PI, Willian da Silveira.
@RenalUCL@ucl@SalfordUni
Check our latest paper on the mouse strain-specific spaceflight-induced changes in kidney gene expression after flying🚀 to the ISS🛰️.
https://t.co/FhN65IUpFx
🚨Booking Open🚨
UCL’s Applied Renal Physiology Course (14-16 May 2025) is now open for registration!
🔑 3 days of learning on electrolyte imbalances, hypertension, and fluid management.
🎓 2 Bursaries Available!
💸 Early Bird – Book by 28th Feb!
🔗 Book: https://t.co/RuJH1SJnDV
📣 Enjoy hearing Dr Siew's Open Science journey that lets you find out why he ends his interview by saying "Free samples, free data: What's not to like?" in this #OSDR Success Stories interview. #SOMA#kidney#SpaceBiology#OpenScience
🎙️ https://t.co/dWkFbM8YJ3
🚀 @KeithSiew@LTubularCentre@physoc@NatureComms
🔗 Siew, K. et al. Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction. Nat Commun 2024. https://t.co/K14PYFYqHr
Delighted to have been highlighted by @NASAGeneLab as one of the #OSDR success stories for 2024. It's been a huge joy and pleasure to get to know so many wonderful people in the space health research community. Check out the links:
https://t.co/2B6sfZHurj
https://t.co/AULgGsvHtD